共 18 条
[1]
Ailes A., Comparative physiological action of the optically isomeric phenisopropylamines, Univ Calif Public Pharmacol, 1, pp. 129-150, (1939)
[2]
Arnold L.E., Huestis R.D., Smeltzer D.J., Scheib J., Wemmer D., Coiner G., Levoamphetamine vs dextroamphetamine in minimal brain dysfunction, Arch Gen Psychiatry, 33, pp. 292-301, (1976)
[3]
Arnold L.E., Kirilcuk V., Corson S.A., Corson E.O., Levoamphetamine and dextroamphetamine: Differential effects on aggression and hyperkinesis in children and dogs, Am J Psychiatry, 130, pp. 165-170, (1973)
[4]
Arnold L.E., Wender P.H., McCloskey K., Snyder S.H., Levoamphetamine and dextroamphetamine: Comparative efficacy in the hyperkinetic syndrome, Arch Gen Psychiatry, 27, pp. 816-822, (1972)
[5]
Asghar K., De Souza E., Pharmacology and Toxicology of Amphetamine and Related Designer Drugs (NIDA Research Monograph 94), (1989)
[6]
Axelrod J., The enzymatic deamination of amphetamine (Benzedrine), J Biol Chem, 214, pp. 753-763, (1955)
[7]
Benakis A., Thomasset M., Metabolism of amphetamines and their interaction with barbiturates and SKF-525A, (1970)
[8]
Bradley C., Benzedrine and Dexedrine in the treatment of children's behavior disorders, Pediatrics, 5, pp. 24-36, (1950)
[9]
Dulcan M.K., Using psychostimulants to treat behavioral disorders in children and adolescents, J Child Adolesc Psychopharmacol, 1, pp. 7-20, (1990)
[10]
Food and Drug Administration: Amphetamines (amphetamine, dextroamphetamine, and their salts, and levamfetamine and its salts) for human use: Statement of policy, (1970)